Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Operating Margin (2017 - 2019)

Historic Operating Margin for Iterum Therapeutics (ITRM) over the last 3 years, with Q1 2019 value amounting to 55313.51%.

  • Iterum Therapeutics' Operating Margin fell 489245100.0% to 55313.51% in Q1 2019 from the same period last year, while for Dec 2019 it was 275732.43%, marking a year-over-year decrease of 2669225400.0%. This contributed to the annual value of 564.66% for FY2024, which is 9422600.0% down from last year.
  • Iterum Therapeutics' Operating Margin amounted to 55313.51% in Q1 2019, which was down 489245100.0% from 10017.99% recorded in Q4 2018.
  • In the past 5 years, Iterum Therapeutics' Operating Margin registered a high of 2637.25% during Q4 2017, and its lowest value of 55313.51% during Q1 2019.
  • Over the past 3 years, Iterum Therapeutics' median Operating Margin value was 8338.38% (recorded in 2018), while the average stood at 13964.39%.
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by -46194000bps in 2018, then crashed by -489245100bps in 2019.
  • Iterum Therapeutics' Operating Margin (Quarter) stood at 2637.25% in 2017, then plummeted by -280bps to 10017.99% in 2018, then plummeted by -452bps to 55313.51% in 2019.
  • Its Operating Margin stands at 55313.51% for Q1 2019, versus 10017.99% for Q4 2018 and 9837.01% for Q3 2018.